Marien Hospital Herne - SunRISe-2
Zu den Inhalten springen
Marien Hospital Herne
St. Elisabeth Gruppe
HomeHome
Klinik für Urologie

SunRISe-2

A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder Who Are Not Receiving Radical Cystectomy

Ansprechpartner

Prof. Dr. med. Florian Roghmann
E-Mail: florian.roghmann@
elisabethgruppe.de
 

Katja Fritz

Katja Fritz
Gesamtleitung Studienkoordination
Fon: 0 23 02 - 173 -13 27
E-Mail: studienkoordination@
elisabethgruppe.de

© Marien Hospital Herne | Impressum | . Datenschutz | . Datenschutz­einstellungen anpassen.